Viviand X, Alaya M, Lokiec F, Ennabli K, Said R, Pecking M, Martin C
Département d'Anesthésie-Réanimation, Hôpital Nord, Marseille, France.
Pathol Biol (Paris). 1995 Apr;43(4):364-9.
Ceftriaxone penetration into heart tissues (valves, myocardium, auricles and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of ceftriaxone administration. Ten patients were given 1,000 g intravenously of ceftriaxone 30 min. before anesthesia. Ten other patients received the same dose and then a second 1,000 mg dose at the time of initiation of cardiopulmonary bypass. Similar and very satisfactory ceftriaxone tissue penetrations were observed in both groups. However, for some patients in the two groups and mainly in the sternal bone at the time of thorax closure, ceftriaxone levels in tissues were less than the MICs for some potential pathogens (Methicillin susceptible Staphylococcus aureus and Staphylococcus epidermidis). During the different steps of the surgical procedures all patients in both groups had tissue levels greater than the MICs for Gram negative aerobic bacilli, except for Pseudomonas spp.
在两种头孢曲松给药方案后,评估了头孢曲松在心脏组织(瓣膜、心肌、心耳和心包)和纵隔组织(脂肪和胸骨)中的渗透情况。10名患者在麻醉前30分钟静脉注射1000毫克头孢曲松。另外10名患者接受相同剂量,然后在体外循环开始时再给予1000毫克剂量。两组均观察到相似且非常令人满意的头孢曲松组织渗透情况。然而,两组中的一些患者,主要是在关胸时胸骨中的患者,组织中的头孢曲松水平低于一些潜在病原体(甲氧西林敏感金黄色葡萄球菌和表皮葡萄球菌)的最低抑菌浓度。在手术过程的不同阶段,两组所有患者的组织水平均高于革兰氏阴性需氧杆菌的最低抑菌浓度,但铜绿假单胞菌属除外。